Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $729.34 | 41 | 90.1% |
| Education | $79.99 | 1 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $335.15 | 18 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $140.87 | 8 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $119.80 | 7 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $95.66 | 2 | $0 (2023) |
| Alkermes, Inc. | $57.65 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.75 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $16.03 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $14.42 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.71 | 3 | Alkermes, Inc. ($43.68) |
| 2023 | $159.57 | 6 | Teva Pharmaceuticals USA, Inc. ($79.99) |
| 2022 | $164.75 | 9 | ABBVIE INC. ($98.53) |
| 2021 | $425.30 | 24 | AbbVie Inc. ($223.67) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: CNS | ||||||
| 01/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: CNS | ||||||
| 12/18/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neuroscience | ||||||
| 10/30/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Neuroscience | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Neuroscience | ||||||
| 09/11/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Neuroscience | ||||||
| 06/21/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $79.99 | General |
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Neuropsychiatry | ||||||
| 09/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: CNS | ||||||
| 05/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Neuroscience | ||||||
| 03/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CNS | ||||||
| 01/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Central Nervous System | ||||||
| 10/14/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neuroscience | ||||||
| 08/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 52 | 138 | $18,433 | $7,340 |
| 2022 | 2 | 36 | 141 | $27,773 | $6,792 |
| 2021 | 2 | 37 | 133 | $28,153 | $6,578 |
| 2020 | 2 | 43 | 195 | $40,857 | $9,003 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 26 | $3,927 | $2,837 | 72.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 12 | 40 | $5,563 | $1,890 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 39 | $6,227 | $1,494 | 24.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 13 | 33 | $2,716 | $1,119 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 76 | $15,034 | $4,006 | 26.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 17 | 65 | $12,739 | $2,786 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 73 | $14,893 | $3,914 | 26.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 18 | 60 | $13,260 | $2,664 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 104 | $20,746 | $4,838 | 23.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 21 | 91 | $20,111 | $4,166 | 20.7% |
About Allison Thomas, NPP-BC
Allison Thomas, NPP-BC is a Registered Nurse healthcare provider based in Norwich, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1477090611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Thomas, NPP-BC has received a total of $809.33 in payments from pharmaceutical and medical device companies, with $59.71 received in 2024. These payments were reported across 42 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($729.34).
As a Medicare-enrolled provider, Thomas has provided services to 168 Medicare beneficiaries, totaling 607 services with total Medicare billing of $29,713. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Norwich, NY
- Active Since 01/26/2017
- Last Updated 07/21/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477090611
Products in Payments
- VRAYLAR (Drug) $335.15
- INVEGA SUSTENNA (Drug) $140.87
- LATUDA (Drug) $119.80
- ARISTADA (Drug) $57.65
- TRINTELLIX (Drug) $29.75
- ABILIFY MAINTENA (Drug) $16.03
- AUSTEDO (Drug) $15.67
- INGREZZA (Drug) $14.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Norwich
Christy Socha, Aprn, APRN
Registered Nurse — Payments: $5,041
Ms. Laura Mcdermott, Fnp, Ms,Rn, FNP, MS,RN
Registered Nurse — Payments: $1,359
Elizabeth Jackson, Aprn, APRN
Registered Nurse — Payments: $579.70
Mrs. Lisa Harrison, Aprn, APRN
Registered Nurse — Payments: $313.08
Bryan Weaver
Registered Nurse — Payments: $302.91
Alexa Cheney
Registered Nurse — Payments: $283.30